Why was I asked to update my Dexcom Follow app?
The latest Follow release contains important updates to the app that improve user experience and enable Dexcom to better serve its customers.
Was this article helpful?
LBL018465 Rev002
Terms and Conditions
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom G7, Dexcom ONE+, Dexcom G6, Dexcom Share, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries.
Always read the label and use only as directed. Read the warnings available on dexcom.com/downloadsandguides before purchasing. Consult your healthcare professional to see if this product is right for you. This product is a continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated.
New Zealand Medical & Scientific Limited is a subsidiary of Dexcom. New Zealand Medical & Scientific, Central Park, 666 Great South Road, Ellerslie, Auckland 1051, New Zealand.
MAT-1606, MAT-3130
• LBL018465 Rev002
© 2026 Dexcom, Inc. All rights reserved.